14,797 Shares in Anterix Inc. $ATEX Purchased by Moody Aldrich Partners LLC

Key Points

• Moody Aldrich Partners acquired 14,797 Anterix shares worth approximately $1.16 million during the third quarter, while institutional investors collectively own 87.67% of the company.
• Anterix insiders sold 124,841 shares valued at roughly $10.98 million in the latest quarter; insiders retain a 40.05% ownership stake.
• Analyst sentiment remains broadly positive, with a consensus “Moderate Buy” rating and an average price target of $120, compared with the stock’s reported opening price of $91.81.

Moody Aldrich Partners LLC bought a new position in Anterix Inc. (NASDAQ:ATEX - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 14,797 shares of the company's stock, valued at approximately $1,162,000. Moody Aldrich Partners LLC owned approximately 0.08% of Anterix as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of ATEX. Integrated Wealth Concepts LLC bought a new position in shares of Anterix during the 2nd quarter valued at $35,000. Sterling Capital Management LLC boosted its holdings in Anterix by 850.0% in the third quarter. Sterling Capital Management LLC now owns 380 shares of the company's stock worth $30,000 after purchasing an additional 340 shares in the last quarter. Parallel Advisors LLC boosted its holdings in Anterix by 63.7% in the first quarter. Parallel Advisors LLC now owns 933 shares of the company's stock worth $36,000 after purchasing an additional 363 shares in the last quarter. Kirr Marbach & Co. LLC IN boosted its holdings in Anterix by 0.4% in the third quarter. Kirr Marbach & Co. LLC IN now owns 116,554 shares of the company's stock worth $9,149,000 after purchasing an additional 485 shares in the last quarter. Finally, Fifth Third Bancorp acquired a new position in Anterix during the first quarter worth $64,000. Institutional investors and hedge funds own 87.67% of the company's stock.

Insider Buying and Selling

In related news, Director Leslie B. Daniels sold 2,500 shares of the stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $83.83, for a total transaction of $209,575.00. Following the completion of the sale, the director owned 43,477 shares in the company, valued at $3,644,676.91. This represents a 5.44% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CMO Heather Martin sold 8,064 shares of the stock in a transaction that occurred on Thursday, September 10th. The shares were sold at an average price of $84.20, for a total value of $678,988.80. Following the sale, the chief marketing officer owned 26,743 shares of the company's stock, valued at approximately $2,251,760.60. The trade was a 23.17% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 124,841 shares of company stock valued at $10,975,765 in the last quarter. Insiders own 40.05% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on ATEX. Clear Str upgraded Anterix to a "strong-buy" rating in a report on Monday, July 27th. JPMorgan Chase & Co. reduced their price target on Anterix from $133.00 to $130.00 and set an "overweight" rating for the company in a research report on Thursday, August 13th. Wall Street Zen downgraded Anterix from a "hold" rating to a "sell" rating in a research note on Saturday, August 15th. Weiss Ratings downgraded Anterix from a "hold (c+)" rating to a "hold (c)" rating in a research note on Monday. Finally, DA Davidson set a $161.00 price objective on Anterix in a report on Friday, August 21st. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $120.00.

Anterix Price Performance

NASDAQ:ATEX opened at $91.81 on Friday. Anterix Inc. has a 12 month low of $17.58 and a 12 month high of $113.00. The company's 50 day moving average is $83.59 and its 200-day moving average is $64.77.

Anterix (NASDAQ:ATEX - Get Free Report) last posted its quarterly earnings data on Tuesday, August 11th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.43) by $0.44. Anterix had a net margin of 933.03% and a negative return on equity of 10.65%. The business had revenue of $1.96 million during the quarter, compared to the consensus estimate of $2.00 million. Sell-side analysts forecast that Anterix Inc. will post -2.00 EPS for the current year.

Anterix Profile

Anterix Inc NASDAQ: ATEX develops and provides private wireless broadband solutions for critical infrastructure industries. The company's primary focus is enabling electric, gas, water and other utilities to deploy secure, resilient communications networks that support operational technology, grid modernization and other mission-critical applications.

Anterix primarily uses its licensed 900 MHz spectrum holdings to support private broadband networks. Its offerings include spectrum access and related wireless communications solutions designed to help utilities connect field equipment, sensors, control systems and mobile workforces.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.